Literature DB >> 16371932

Sex steroid ablation enhances lymphoid recovery following autologous hematopoietic stem cell transplantation.

Gabrielle L Goldberg1, Jayne S Sutherland, Maree V Hammet, Morag K Milton, Tracy S P Heng, Ann P Chidgey, Richard L Boyd.   

Abstract

BACKGROUND: Autologous hematopoietic stem cell transplantation (auto-HSCT) patients experience long-term immunosuppression, which increases susceptibility to infection and relapse rates due to minimal residual disease (MRD). Sex steroid (SS) ablation is known to reverse age-related thymic atrophy and decline in B-cell production
METHODS: This study used a congenic HSCT mouse model to analyze the effects of SS ablation (through surgical castration) on immune reconstitution and growth factor production following auto-HSCT. Bone marrow (BM) and thymic stromal cell (TSCs) populations were analyzed using RT-PCR and were tested for the production of growth factors previously implicated in immune reconstitution or age-relate immune degeneration
RESULTS: Castration increased bone marrow (BM), thymic, and splenic cellularity following auto-HSCT. HSC number and common lymphoid precursor (CLP) frequency and number were increased in castrated mice. B cell precursor numbers were also significantly increased in the BM of these mice. Triple negative, double positive and single positive thymocytes were increased following HSCT and castration, as were thymic dendritic cells and natural killer T (NKT) cells. This enhanced lymphoid reconstitution of the primary immune organs leads to a significant increase in splenic T and B cells 42 days after HSCT. The molecular mechanisms behind the enhanced reconstitution were also studied. TGF-beta1 was decreased in castrated mice compared to sham-castrated controls in TSCs and BM cells. TSC production of IL-6 was also decreased in castrated mice
CONCLUSIONS: These data suggest that sex steroid ablation significantly enhances lymphopoiesis following auto-HSCT providing a new strategy for posttransplant immune reconstitution.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16371932     DOI: 10.1097/01.tp.0000183962.64777.da

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  38 in total

1.  Regeneration of dendritic cells in aged mice.

Authors:  Serani L H van Dommelen; Alexandra Rizzitelli; Ann Chidgey; Richard Boyd; Ken Shortman; Li Wu
Journal:  Cell Mol Immunol       Date:  2010-02-01       Impact factor: 11.530

Review 2.  Adoptive precursor cell therapy to enhance immune reconstitution after hematopoietic stem cell transplantation.

Authors:  J L Zakrzewski; A M Holland; M R M van den Brink
Journal:  J Mol Med (Berl)       Date:  2007-02-28       Impact factor: 4.599

3.  Twisting immune responses for allogeneic stem cell therapy.

Authors:  Shengwen Calvin Li; Jiang F Zhong
Journal:  World J Stem Cells       Date:  2009-12-31       Impact factor: 5.326

Review 4.  Clinical strategies to enhance T cell reconstitution.

Authors:  Gabrielle L Goldberg; Johannes L Zakrzewski; Miguel A Perales; Marcel R M van den Brink
Journal:  Semin Immunol       Date:  2007-10-26       Impact factor: 11.130

Review 5.  Clinical strategies to enhance posttransplant immune reconstitution.

Authors:  Irwin D Bernstein; Richard L Boyd; Marcel R M van den Brink
Journal:  Biol Blood Marrow Transplant       Date:  2008-01       Impact factor: 5.742

Review 6.  Strategies for reconstituting and boosting T cell-based immunity following haematopoietic stem cell transplantation: pre-clinical and clinical approaches.

Authors:  Ann P Chidgey; Natalie Seach; Jarrod Dudakov; Maree V Hammett; Richard L Boyd
Journal:  Semin Immunopathol       Date:  2008-11-04       Impact factor: 9.623

7.  CCL25 increases thymopoiesis after androgen withdrawal.

Authors:  Kirsten M Williams; Philip J Lucas; Catherine V Bare; Jiun Wang; Yu-Waye Chu; Ezekiel Tayler; Veena Kapoor; Ronald E Gress
Journal:  Blood       Date:  2008-08-11       Impact factor: 22.113

Review 8.  Thymic rejuvenation and aging.

Authors:  Melissa S Ventevogel; Gregory D Sempowski
Journal:  Curr Opin Immunol       Date:  2013-07-04       Impact factor: 7.486

Review 9.  Enhancing efficacy of therapeutic vaccinations by combination with other modalities.

Authors:  James L Gulley; Ravi A Madan; Philip M Arlen
Journal:  Vaccine       Date:  2007-06-04       Impact factor: 3.641

Review 10.  Rejuvenation of the aging T cell compartment.

Authors:  Amanda M Holland; Marcel R M van den Brink
Journal:  Curr Opin Immunol       Date:  2009-07-14       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.